Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
11 11 Search
2025
ND-630, an acetyl-CoA carboxylase inhibitor, prevents renal fibrosis in adenine-induced CKD mice
Naunyn-Schmiedeberg's Archives of Pharmacology
2025
Characterization of six clinical drugs and dietary intervention in the nonobese CDAA-HFD mouse model of MASH and progressive fibrosis
American Journal of Physiology-Gastrointestinal and Liver Physiology
2023
Knockout of Purinergic P2Y6 Receptor Fails to Improve Liver Injury and Inflammation in Non-Alcoholic Steatohepatitis
International Journal of Molecular Sciences
2023
Filamin A is overexpressed in non-alcoholic steatohepatitis and contributes to the progression of inflammation and fibrosis
Biochemical and Biophysical Research Communications
2023
Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3/CPT1 pathway
Biomedicine & Pharmacotherapy
2021
Transcriptomic analysis of the liver in aged laying hens with different intensity of brown eggshell color
Animal Bioscience
2021
Design and synthesis of a monocyclic derivative as a selective ACC1 inhibitor by chemical modification of biphenyl ACC1/2 dual inhibitors
Bioorganic & Medicinal Chemistry
2021
One Week of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver
International Journal of Molecular Sciences
2021
Pparg signaling controls bladder cancer subtype and immune exclusion
Nature Communications
2020
Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis
Expert Opinion on Pharmacotherapy
Additional cited-by details will be shown when available from Crossref